Share This Article:

Synthesis and Evaluation of Glyceride Prodrugs of Naproxen

Abstract Full-Text HTML Download Download as PDF (Size:558KB) PP. 87-92
DOI: 10.4236/ojmc.2013.33011    4,675 Downloads   8,897 Views   Citations

ABSTRACT

The glyceride ester derivatives 6a and 6b were prepared by reacting 1,2,3-trihydroxy propane 1,3-dipalmitate/stearate with (S)-naproxen as potential prodrugs. The synthesis was achieved successfully with the aid of N,N’-dicyclohexyl- carbodiimide. These prodrugs were evaluated for anti inflammatory, analgesic and gastroprotective activity. It was found that prodrugs 6a and 6b showed less irritation to gastric mucosa as indicated by ulcer index. The synthesized glyceride esters were found to possess good pharmacological profile as shown by results of anti inflammatory and analgesic activity. The aqueous studies were performed in order to ensure the release of prodrugs. Both prodrugs were found to stable at acidic pH while undergoes hydrolysis at pH 7.4. These findings suggest that the glyceride prodrugs 6a and 6b might be used as potential biolabile derivatives.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

V. Redasani and S. Bari, "Synthesis and Evaluation of Glyceride Prodrugs of Naproxen," Open Journal of Medicinal Chemistry, Vol. 3 No. 3, 2013, pp. 87-92. doi: 10.4236/ojmc.2013.33011.

References

[1] P. K. Halen, P. R. Murumkar, R. Giridhar and M. R. Yadav, “Prodrug Designing of NSAIDs,” Mini-Reviews in Medicinal Chemistry, Vol. 9, No. 1, 2009, pp. 124-139. doi:10.2174/138955709787001695
[2] J. R. Vane, Y. S. Bakhle and R. M. Bolting, “Cycloxygenase 1 and 2,” Annual Review of Pharmacology and Toxicology, Vol. 38, No. 1, 1998, pp. 97-102. doi:10.1146/annurev.pharmtox.38.1.97
[3] N. Bodor, “Retrometabolic Approaches for Drug Design and Targeting,” Pharmazie, Vol. 52, No. 7, 1997, pp. 491-494.
[4] M. S. Y. Khan and M. Akhter, “Glyceride Derivatives as Potential Prodrugs: Synthesis, Biological Activity and Kinetic Studies of Glyceride Derivatives of Mefenamic Acid,” Pharmazie, Vol. 60, No. 2, 2005, pp. 110-114.
[5] P. Sharma, S. Yadav, R. Pahwa, D. Kaushik and S. Jain, “Synthesis and Evaluation of Novel Prodrugs of Naproxen,” Medicinal Chemistry Research, Vol. 20, No. 5, 2011, pp. 648-655. doi:10.1007/s00044-010-9364-8
[6] G. Y. Paris, D. L. Garmaise, D. G. Cimon, L. Swett, G. W. Carter and P. Young, “Glycerides as Prodrugs: Synthesis and Antiinflammatory Activity of 1,3-Bis(alkanoyl)-2-(O-acetylsalicyloy) Glycerides (Aspirin Triglycerides),” Journal of Medicinal Chemistry Vol. 22, No. 6, 1979, pp. 683-687. doi:10.1021/jm00192a014
[7] G. Y. Paris, D. L. Garmaise and D. G. Cimon, “Glycerides as Prodrugs. 3. Synthesis and Antiinflammatory Activity of [1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl]glycerides (Indomethacin Glycerides),” Journal of Medicinal Chemistry, Vol. 23, No. 1, 1980, pp. 9- 12. doi:10.1021/jm00175a003
[8] L. El Kihel, J. Bourass, P. Richomme, J. Y. Petit and Y. Letourneux, “Synthesis and Antiinflammatory Activity of Niflumic Acid Lipophilic Prodrugs in Brain Edema,” Arzneimittel-Forschung/Drug Research, Vol. 46, No. 11, 1996, pp. 1040-1044.
[9] M. S. Y. Khan and M. Akhter, “Synthesis, Biological Evaluation and Kinetic Studies of Glyceride Prodrugs of Diclofenac,” Indian Journal of Experimental Biology, Vol. 42, No. 11, 2004, pp. 1066-1072.
[10] M. S. Y. Khan and M. Akhter, “Synthesis, Pharmacological Activity and Hydrolytic Behavior of Glyceride Prodrugs of Ibuprofen,” European Journal of Medicinal Chemistry, Vol. 40, No. 4, 2005, pp. 371-376. doi:10.1016/j.ejmech.2004.11.009
[11] M. S. Y. Khan, M. Akhter and A. Husain, “Synthesis Biological Evaluation and Kinetic Studies of Glyceride Prodrugs of Biphenyl Acetic Acid,” Indian Journal of Chemistry, Vol. 45B, No. 4, 2006, pp. 1014-1019.
[12] C. A. Winter, E. A. Risley and G. W. Nuss, “Carrageenin- Induced Edema in Hind Paw of the Rat as an Assay for Anti Inflammatory Drugs,” Proceedings of the Society for Experimental Biology and Medicine, Vol. 111, 1962, pp. 544-547.
[13] M. R. Yadav, M. N. Datta, A. Ananthakrishnan, S. B. Pathik, T. S. Shrikant, G. Rajani, P. Arvind and R. Balaraman, “Synthesis of New Chemical Entities from Paracetamol and NSAIDs with Improved Pharmacodynamic Profile,” Bioorganic & Medicinal Chemistry, Vol. 14, No. 24, 2006, pp. 8701-8706. doi:10.1016/j.bmc.2006.08.017
[14] V. Cioli, S. Putzolu, V. Rossi, P. S. Barcellona and C. Corradino, “The Role of Direct Tissue Contact in the Production of Gastrointestinal Ulcers by Anti-Inflammatory Drugs in Rats,” Toxicology and Applied Pharmacology, Vol. 50, No. 2, 1979, pp. 283-287. doi:10.1016/0041-008X(79)90153-4
[15] B. T. Ali, F. M. Monther and H. M. Mohammed, “Design, Synthesis and Hydrolysis Study of Mutual Prodrugs of NSAIDs with Different Antioxidants via Glycolic Acid Spacer,” International Journal of Comprehensive Pharmacy, Vol. 1, No. 3, 2012, p. 3.
[16] M. F. Zaida, P. S. Elisabete, F. R. Jo, M. D. Gisela and C. S. G. Jos, “A New Sunscreen of the Cinnamate Class: Synthesis and Enzymatic Hydrolysis Evaluation of Glyceryl Esters of P-Methoxycinnamic Acid,” European Journal of Pharmaceutical Sciences, Vol. 25, No. 1, 2005, pp. 67-72. doi:10.1016/j.ejps.2005.01.018
[17] V. K. Redasani and S. B. Bari, “Synthesis and Evaluation of Mutual Prodrugs of Ibuprofen with Menthol, Thymol, and Eugenol,” European Journal of Medicinal Chemistry, Vol. 56, 2012, pp. 134-138. doi:10.1016/j.ejmech.2012.08.030
[18] A. Mishra, R. Veerasamy, P. K. Jain, V. K. Dixit and R. K. Agrawal, “Synthesis, Characterization and Pharmacological Evaluation of Amide Prodrugs of Flurbiprofen,” Journal of the Brazilian Chemical Society, Vol. 19, No. 1, 2002, pp. 89-100.
[19] N. Voilley, “Acid-Sensing Ion Channels (ASICs): New targets for the Analgesic Effects of NSAIDs,” Current Drug Target—Inflammation & Allergy, Vol. 3, No. 1, 2004, pp. 71-79.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.